And its immense potential in revolutionizing clinical trial design, drug development, and precision medicine

Over the past year, the COVID-19 pandemic has shed increasing awareness on the importance of the biotechnology sector and its pivotal role in ushering novel discoveries in research and development (R&D), treatments, and cures.

The emergence of Techbio companies represents a new era of data-enabled discovery paradigms, whereby biological, human health, and enterprise data are functionally extrapolated to create better standards of care and accelerate the next generation of scientific breakthroughs.

Krish Ramadurai

VC partner at Harmonix Fund, karate master, and science nerd. On a mission to accelerate the scientific breakthroughs of tomorrow, today.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store